The vaccine adjuvants market is consolidated in nature due to the presence of a few large players. Prominent players in the vaccine adjuvants market include Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc., and OZ Biosciences (France).

Get Full PDF Sample Copy of Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894

Brenntag Biosector (Denmark) was the global leader in the vaccine adjuvants market in 2015. The company is a subsidiary of Brenntag AG (Germany). It is a well-known company and has an exhaustive product portfolio. The company is innovation-centric and invests heavily in R&D for maintaining its market share. The company also focuses on inorganic growth strategies such as agreements to enhance its market share. For instance, Brenntag Biosector A/S (Denmark) signed an agreement with MoreinX AB (Sweden) for the commercialization of nanoparticle-based vaccine adjuvants. This agreement helped expand the company’s novel offerings for vaccine adjuvants in the market.

SEPPIC (France) held the second position in the vaccine adjuvants market in 2015. This can be attributed to the company’s strong portfolio of vaccine adjuvants. The company adopts organic growth strategies such as expansions to boost its market share. For instance, SEPPIC (France) launched a production and sterile packaging unit for vaccine adjuvants and injectables by investing USD 6.66 million in Castres, France. This facility launched helped expand the company’s production capacity in the vaccine adjuvants market and enabled it to become the first company to introduce packaging of veterinary vaccine adjuvants in large volumes.

The key strategies followed by most companies in the vaccine adjuvants market are inorganic strategies such as partnerships, agreements, and collaborations; mergers and acquisitions; and expansions. The strategy of partnerships, agreements, and collaborations accounted for the largest share of the overall growth strategies mapped from 2013 to 2016. Some of the leading players that adopted this strategy include Brenntag Biosector (Denmark), CSL Limited (Australia), and SEPPIC (France). Mergers & acquisitions accounted for the second-largest share of the overall growth strategies adopted by players in this market.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]